成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天
深圳卓越生物醫(yī)藥科技有限公司 Company Information
Company Name:
Shenzhen Excellent Biomedical Technology Co., Ltd.
Tel:
-
Email:
2850803126@qq.com
Nationality:
China
WebSite:
www.ex-biotech.com/
Product List:
5034
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
Product List
Itraconazole Epimer
Atenolol Impurity 1
81346-71-6
Atenolol EP Impurity I
1797116-92-7
Atenolol
29122-68-7
Atenolol EP Impurity F
87619-83-8
Atenolol EP Impurity E
141650-31-9
Itraconazole Impurity G
Itraconazole EP Impurity B
854372-77-3
Atenolol EP Impurity D
115538-83-5
Gliclazide Impurity 5
39051-77-9
Gliclazide Impurity 6
1207714-41-7
Gliclazide
21187-98-4
Gliclazide Impurity 1
38173-52-3
Gliclazide Impurity 2
14437-03-7
Gliclazide Impurity 3 HCl
58108-05-7
Gliclazide Impurity 4
107628-27-3
Atenolol Impurity C
29122-69-8
Atenolol EP Impurity B
61698-76-8
Atenolol EP Impurity A
17194-82-0
Itraconazole Impurity 14
67914-86-7
N-Desalkyl Itraconazole
89848-41-9
Itraconazole N-Glucuronide
Itraconazole N-Formyl-Ethlene Impurity
1199350-00-9
Itraconazole EP Impurity A
252964-68-4
Itraconazole EP Impurity C
74855-91-7
Itraconazole EP Impurity D
89848-49-7
Itraconazole EP Impurity E
252964-65-1
Itraconazole EP Impurity F
89848-51-1
Itraconazole N-Oxide
Gliclazide EP Impurity B
54786-86-6
Orlistat
96829-58-2
Orlistat Related Compound D
130793-27-0
Gliclazide EP Impurity D
1136426-19-1
Gliclazide EP Impurity G
Gliclazide EP Impurity E
1808087-53-7
Orlistat USP Related Compound A
104872-06-2
Orlistat USP Related Compound B
19740-72-8
Orlistat USP Related Compound C
791-28-6
Orlistat USP Related Compound E
1072902-75-0
Atenolol Impurity D
Atenolol Impurity F
156-38-7
Atenolol EP Impurity H
29277-73-4
Atenolol EP Impurity G Sodium Salt
56392-14-4
Gliclazide EP Impurity C
5577-13-9
Gliclazide EP Impurity F
1076198-18-9
Guaifenesin EP Impurity B
14007-09-1
Lenalidomide
191732-72-6
Lenalidomide Impurity 7
2197414-55-2
Lenalidomide Glucosides
Linagliptin
668270-12-0
Linagliptin Impurity 41
1638744-06-5
Linagliptin Impurity 15
1803079-49-3
Guaifenesin EP Impurity C
1797132-23-0
Guaifenesin EP Impurity D
16929-60-5
Guaifenesin
93-14-1
Nicotinic Acid EP Impurity E;Isoniazid EP Impurity A
55-22-1
Isoniazid EP Impurity B
1453-82-3
Isoniazid Impurity 1
15420-02-7
Linagliptin Impurity 18
1646355-34-1
Linagliptin Impurity 43
668273-75-4
Linagliptin Impurity 42
666816-98-4
Linagliptin Impurity 21
666816-91-7
Aciclovir ;Acyclovir EP Impurity K
1797131-64-6
Aciclovir ;Acyclovir EP Impurity J
166762-90-9
Acyclovir ;Aciclovir EP Impurity P
23169-33-7
Aciclovir ;Acyclovir EP Impurity M
91702-60-2
Linagliptin Impurity 27
1446263-38-2
Rosuvastatin EP Impurity G Sodium Salt
1242184-42-4
Rosuvastatin Impurity 73
1797419-58-9
Rosuvastatin EP Impurity L
Rosuvastatin EP Impurity C
1422619-13-3
Rosuvastatin EP Impurity C Sodium Salt
1620823-61-1
Rosuvastatin EP Impurity D
503610-43-3
Acyclovir ;Aciclovir EP Impurity F
110104-37-5
Acyclovir ;Aciclovir EP Impurity L
3056-33-5
Acyclovir ;Aciclovir EP Impurity C
91702-61-3
Acyclovir ;Aciclovir EP Impurity A
102728-64-3
Acyclovir ;Aciclovir EP Impurity G
75128-73-3
Acyclovir ;Aciclovir Impurity H
133186-23-9
Rosuvastatin EP Impurity K Sodium Salt
2290571-51-4
Rosuvastatin 4,6-Diene Impurity
1422954-13-9
3-O-Ethyl Rosuvastatin
Rosuvastatin EP Impurity M Sodium Salt
847849-66-5
Metoclopramide EP Impurity F
38339-95-6
Metoclopramide EP Impurity G
171367-22-9
Metoclopramide EP Impurity H
50-86-2
Rosuvastatin EP Impurity I Calcium Salt
Rosuvastatin Impurity H Sodium Salt
1335110-44-5
Rosuvastatin EP Impurity F
289042-12-2
Rosuvastatin Calcium Salt
147098-20-2
Mesalazine EP Impurity E
65-49-6
Mesalazine Impurity ZY2
Metoclopramide EP Impurity B
4093-31-6
Rosuvastatin EP Impurity A Sodium Salt
1714147-50-8
N-Acetyl Metoclopramide HCl
Rosuvastatin EP Impurity J Sodium Salt
Rosuvastatin EP Impurity E Sodium Salt
Dacomitinib
1110813-31-4
Dacomitinib Impurity 1
179552-75-1
Dacomitinib Impurity ZY1
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
Copyright 2007© ChemicalBook. All rights reserved.